Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human KCNJ16 ELISA Kit (AC3451)
Cat.#: ASET-2040
Specifications
Description Human KCNJ16 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human KCNJ16 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.05 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1-16 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1617 Mouse GALC ELISA Kit (AC3028) Quantitative inquiry ASET-1277 Rat BACE2 ELISA Kit (AC2688) Quantitative inquiry ASET-1384 Mouse MMP24 ELISA Kit (AC2795) Quantitative inquiry ASET-2020 Human Angiogenin ELISA Kit (AC3431) Quantitative inquiry ASET-1319 Guinea Pig BDNF ELISA Kit (AC2730) Quantitative inquiry ASET-2461 Human GRIP1 ELISA Kit (AC3872) Quantitative inquiry ASET-1770 Rat AVPR1B ELISA Kit (AC3181) Quantitative inquiry ASET-1637 Human PPAR gamma ELISA Kit (AC3048) Quantitative inquiry ASET-1265 Human Syntaxin 4 ELISA Kit (AC2676) Quantitative inquiry ASET-1022 Human Neurexin 1 ELISA Kit (AC2433) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket